Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-β) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-cell lung cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Lung Cancer

• Publication date

  2011-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cllc.2011.02.002PMID 21729646PMCID PMC3643693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors.

  2009cited by this paper
• EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer

  2009cited by this paper
• Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells

  2008cited by this paper
• Pleomorphic Carcinoma of the Lung: Clinicopathologic Characteristics of 70 Cases

  2008cited by this paper
• Sarcomatoid carcinoma of the lung: a predictor of poor prognosis.

  2007cited by this paper
• Sarcomatoid lung cancer (spindle/giant cells): an aggressive disease?

  2007cited by this paper
• Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas.

  2005cited by this paper
• Personal experience in surgical management of pulmonary pleomorphic carcinoma.

  2004cited by this paper
• Pulmonary Carcinomas With Pleomorphic, Sarcomatoid, or Sarcomatous Elements: A Clinicopathologic and Immunohistochemical Study of 75 Cases

  2003cited by this paper
• Pleomorphic Carcinomas of the Lung Show a Selective Distribution of Gene Products Involved in Cell Differentiation, Cell Cycle Control, Tumor Growth, and Tumor Cell Motility: A Clinicopathologic and Immunohistochemical Study of 31 Cases

  2003cited by this paper
• Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.

  2002cited by this paper
• Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases

  2002cited by this paper
• The new World Health Organization classification of lung tumours

  2001cited by this paper
• Carcinosarcomas of the lung: a clinicopathologic study of 66 patients.

  1999cited by this paper
• Sarcomatoid carcinoma of the lung

  1999cited by this paper
• Expression in lung carcinomas of platelet-derived growth factor and its receptors.

  1997cited by this paper
• Sarcomatoid carcinomas of the lung: a clinicopathologic review.

  1997cited by this paper
• Biphasic sarcomatoid carcinoma of the lung: report of 5 cases and review of the literature.

  1997cited by this paper
• Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases

  1994cited by this paper
• Sarcomatoid carcinoma of the lung. Immunohistochemieal and ultrastructural studies of 14 cases

  1992cited by this paper
• Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products.

  1992cited by this paper

• Construction of Gene Regulatory Networks Based on Spatial Multi-Omics Data and Application in Tumor-Boundary Analysis

  2025cites this paper
• Integrated meta-analyses of genome-wide effects of PM2.5 in human cells identifies widespread dysregulation of genes and pathways associated with cancer progression and patient survival.

  2024cites this paper
• Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers

  2024cites this paper
• Analysis of CD74 Occurrence in Oncogenic Fusion Proteins

  2023cites this paper
• Flavonoids as receptor tyrosine kinase inhibitors in lung cancer

  2023cites this paper
• Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer

  2021cites this paper
• PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer

  2021cites this paper
• The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer

  2020influential citation
• Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling

  2020cites this paper
• Platelet indices in non-small cell lung cancer patients with brain metastases

  2019cites this paper
• Targeting platelet-derived growth factor receptor β inhibits the proliferation and motility of human pterygial fibroblasts

  2019cites this paper
• Investigation into the underlying molecular mechanisms of non-small cell lung cancer using bioinformatics analysis

  2019cites this paper
• Tyrosine Kinase Inhibitor Imatinib Mesylate Alters DMBA-Induced Early Onco/Suppressor Gene Expression with Tissue-Specificity in Mice

  2019cites this paper
• Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.

  2018cites this paper
• Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.

  2018cites this paper
• Involvement of platelet‐derived growth factor ligands and receptors in tumorigenesis

  2018cites this paper
• Stromal PDGFR-β Expression is Associated with Postoperative Survival of Non-Small Cell Lung Cancer Patients Receiving Preoperative Chemo- or Chemoradiotherapy Followed by Surgery

  2018cites this paper
• Determination of 16 serum angiogenic factors in stage I non-small cell lung cancer using a bead-based multiplex immunoassay.

  2017cites this paper
• Platelet distribution width correlates with prognosis of non-small cell lung cancer

  2017cites this paper
• The regulation of cell signalling by LAR protein tyrosine phosphatase

  2017cites this paper
• GZD856, a novel potent PDGFRα/β inhibitor, suppresses the growth and migration of lung cancer cells in vitro and in vivo.

  2016cites this paper
• Identification and characterization of the genetic alterations underlying neuroendocrine tumors of the small intestine

  2016cites this paper
• Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers

  2016cites this paper
• The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer

  2016cites this paper
• Impact of p53 and PDGFR-β Expression on Metastasis and Prognosis of Patients with Pancreatic Cancer

  2016cites this paper
• Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma.

  2015cites this paper
• Platelet-derived growth factor signaling in the lung. From lung development and disease to clinical studies.

  2015cites this paper
• 血小板源生长因子家族在非小细胞肺癌中的研究进展

  2014cites this paper
• ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC

  2014cites this paper
• Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies

  2014cites this paper
• Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases

  2013cites this paper
• Targeting receptor tyrosine kinases in solid tumors.

  2013cites this paper
• Mechanisms of TKI-induced diarrhea in cancer patients

  2013cites this paper
• Targeting the PDGF signaling pathway in tumor

  2013cites this paper
• Targeting the PDGF signaling pathway in tumor treatment

  2013cites this paper
• Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer.

  2012cites this paper